Evidence map›Paper›PMID 35706896›Full record

ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2022

Landiolol for refractory tachyarrhythmias in the intensive care unit: case reports.

Clemens Gangl, Konstantin A Krychtiuk, Robert Schoenbauer, Walter S Speidl

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European heart journal supplements : journal of the European Society of Cardiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Clemens GanglDepartment of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria.
Konstantin A KrychtiukDepartment of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria.
Robert SchoenbauerDepartment of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria.
Walter S SpeidlDepartment of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria.
Medical University of Vienna · ATLudwig Boltzmann Institute for Cancer Research · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tachyarrhythmias are common complications of critically ill patients treated on intensive care units. Landiolol is an ultra-short acting beta-blocker with a very high beta1-selectivity. Therefore, landiolol effectively reduces heart rate with only minimal negative effects on blood pressure and inotropy. This article describes two cases of successful treatment of supraventricular and ventricular tachycardias with landiolol in critically ill patients.

Indexed as

Case reportElectrical stormLandiololSepsis

Identifiers

PMID35706896
PMCPMC9190750
OpenAlexW4226031677

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.